Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids

Cancer Immunology, Immunotherapy

Volumn 50, Issue 6, 2001, Pages 300-306

  Heimdal, J H ^a   Olsnes, C ^a   Olofsson, J ^a   Aarstad, H J ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Co culture; F spheroids; Macrophages; MCP 1; Monocytes

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; TUMOR SPHEROID;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CHEMOKINE CCL2; COCULTURE TECHNIQUES; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; MOUTH MUCOSA; RNA, MESSENGER; SPHEROIDS, CELLULAR;

EID: 0034891897     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620100204     Document Type: Article

References (34)

1. Tumour immunology: False hopes- new horizons?
2. Induction of natural killer cell migration by monocyte chemotactic protein-1,-2,-3
3. Adoptive immunotherapy of cancer using monocyte-derived macrophages: Rationale, current status and perspectives
4. Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines
5. Tumor necrosis factor: Function, release and clearance
6. Tumor-associated macrophages (TAM) in the stroma of squamous cell carcinomas of the ENT area studied using monoclonal antibodies
7. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line
8. Involvement of inflammatory mediators in macrophage antitumor activity
9. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis
10. Regulation of the macrophage content of neoplasms by chemoattractants
11. Ability of cancer patients' macrophages to kill autologous tumor targets. Effect of prostaglandin inhibitors on cytotoxicity
12. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin
13. Recognition and destruction of neoplastic cells by activated macrophages: Discrimination of altered self
14. Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture
15. Monocyte chemotactic proteins from human tumor cells
16. The role of MCP-1 in atherosclerosis
17. T-lymphocyte function in head and neck cancer patients
18. Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients
19. Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14 dependent pathway
20. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes
21. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen
22. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor
23. Secretion of monocyte chemoattractant protein-1 (MCP-1) by human mononuclear phagocytes
24. The origin and function of tumor-associated macrophages
25. Macrophage infiltration and tumor progression
26. The human homolog of the JE gene encodes a monocyte secretory protein
27. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
28. Human respiratory mucosa in a nonadhesive stationary organ culture system
29. Role of tumor-associated macrophages in lung cancer
30. Monocyte chemotactic protein-1 (MCP-1),-2 and -3 are chemotactic for human T-lymphocytes
31. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer
32. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium
33. Natural killer cells and tumor therapy
34. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants